Profiting From Pain: Who’s Behind America’s Opioid Epidemic? Part II
A follow up on Eric Striker’s seminal article on the opioid epidemic.
In memory of the 140,931 dead of drug overdoses in the three years since.
The opioid crisis is back in the news, in part from a blockbuster settlement between Purdue and Oklahoma and in part because discovery in hundreds of civil lawsuits is revealing the shocking scale of the criminality of the Sackler family and their co-conspirators. The deaths of 400,000, predominately White Americans from opioid overdoses can no long be ignored by the system. Unfortunately in-depth articles from White Advocates are rare.
Of those that have been written, the most touching is Emil Kraepelin’s January 2019 article in the Republic Standard. Emil described the risk factors of addiction and demonstrated that the burden of the crisis falls primarily on Whites. But those who hate American Whites now have their own explanation for the disproportionate addiction of our people.
I have noticed a disturbing trend among the mainstream press of blaming White Privilege for the fact that Whites are dying of opioid overdoses at 150% the rate of Blacks and 285% the rate of Hispanics. The gist of the argument is that doctors empathize with Whites more, so they over-prescribed these opioids out of kindness! This narrative, publicized in the Jewish press, must be countered by White Advocates, or else the slow death of White America will continue to be ignored by academics and policymakers. With the latest research and legal disclosures on the opioid crisis, I aim to shatter this latest attempt by academia and the media to blame Whites for our own suffering.
The Jewish Counter-Narrative Develops
The Judenpresse have noticed the opioid crisis—not as a humanitarian concern—but as a dangerous claim to a White collective interest. Of our country’s 399,202 dead from opioid overdoses from 1999 to 2017, 323,911 (81%) were non-Hispanic White. Titles of recent articles include, “Amid the opioid epidemic, white means victim, black means addict,” in the Guardian. The LA Times titled one piece, “Why opioids hit white areas harder: Doctors there prescribe more readily, study finds.” The LA Times trumpeted a study by one Joseph Friedman who blamed the disproportionate White overdoses on “systemic racism.”
NPR asked, “Why Is The Opioid Epidemic Overwhelmingly White?” and brought on the Brandeis University Co-Director of Opioid Policy Research, Andrew Kolodny, to Jew-splain the disparate impact on Whites. Kolodny answered:
Something that we do know is that doctors prescribe narcotics more cautiously to their non-white patients. It would seem that if the patient is black, the doctor is more concerned about the patient becoming addicted, or maybe they're more concerned about the patient selling their pills, or maybe they are less concerned about pain in that population. But the black patient is less likely to be prescribed narcotics, and therefore less likely to wind up becoming addicted to the medication. So what I believe is happening is that racial stereotyping is having a protective effect on non-white populations.
It's a comforting story for the Jewish press. The tens of thousands of dead Whites in the opioid crisis were victims of their own White Privilege. Their inherent Whiteness led their doctors to overprescribe them poison out of empathy. But according to the press, the White Privilege of the opioid crisis does not end there.
Whites further “benefit” from our President’s limp-wristed response to the crisis. Condé Nast’s House Negro, Lincoln Anthony Blades titled his Teen Vogue op-ed, “The Opioid Crisis Only Became a Crisis When It Affected White People.” In it, Blades complains that the Trump administration threw Whites a $81 million pittance for opioid addiction programs that would presumably be better used for reparations. Blades writes:
When the crack epidemic hit America in the 1980s, there was little talk from politicians about managing a ‘public health crisis,’ nor were the addicts and the victims of overdoses subject to humanizing stories about the ills of overcoming addiction. Instead, suffering in poor black and brown communities was met with zero tolerance and mass incarceration.
Of course, Blades fails to mention the crucial difference between the opioid crisis and the crack epidemic. The crack epidemic was driven by Black dealers in the hood holding corners. The opioid crisis is driven by international Jewish Pharmaceutical companies. Prior to Trump’s criminal justice reform, the system could tolerate jailing Black drug pushers. However, not one Purdue Pharma executive or member of the Sackler family has spent a single day in jail.
Compare the nature of how drug users got hooked in the crack-era. Of people entering treatment for heroin addiction who began abusing opioids in the 1960s, more than 80% started with heroin. Today, nearly 80% of heroin users reported using prescription opioids prior to heroin.
Rather than a result of White Privilege, the lack of arrests is a sign of the federal government’s contempt for Whites. If only the Feds would arrest the crooked pharmacists who sold pills on the side, or the doctors who took all-expenses-paid vacations from Purdue, or maybe, just maybe, the parasites that run our pharmaceutical industry. But no! While Teva and the Sacklers shuttle their ill-gotten gains to Israel, Donald Trump allocated $3.8 billion this year for the Jewish state, more than double the NIH’s Opioid-related grant funding.
Jewish Lawyers Embrace the White Privilege Hypothesis
Elana Cohen’s National Lawyers Guild (NLG) also has the audacity to blame the Opioid Crisis on White Privilege. The NLG’s embrace of this White Privilege Hypothesis is particularly dangerous given its clout among our prosecutors and law professors. The NLG’s most recent article on the Opioid Epidemic was blasted out by email to the 8,000 lawyers and law students who are members of the NLG.
The objective is obvious, to deafen the ears of our judicial elites to White claims of exploitation by Jewish pharmaceutical companies. To this end, the Jewish Judge Polster, presiding over the 1,600-plaintiff federal opioid lawsuit by states, municipalities, and Indian Tribes has declared he will not bother “unraveling complicated conspiracy theories.” He pushed the plaintiffs to settle before discovery of pharmaceutical company documents could begin, and when that failed, he ordered that documents obtained through discovery be kept secret from the public.
Speaking to the Anti-Defamation League about immigration policy at a local synagogue in 2017, Polster revealed, “That’s why it’s important to have judges of diversity – each of us sees the world through our lens …. a big part of my lens is because of my Jewish upbringing and beliefs.”
I agree with the sentiment—at least the last bit. The Jewish family at the center of the opioid crisis, the Sacklers, and the Jewish CEOs of the opioid distributors Teva, Allergan, and AmerisourceBergen certainly viewed the world through their Jewish lenses. The same goes for the Jewish institutional investors who control the majority of ENDO International shares. And I reckon that former Clinton Deputy Attorney General, Jamie Gorelick, was motivated by her own Jewish upbringing and beliefs when she conspired with Obama’s principal Deputy Attorney General, Stuart M. Goldberg, to prevent the shutdown of Cardinal Health’s southern distribution warehouse by the DEA while it pushed out 36 million opioids per month.
The Jews at the NLG would never dream of mentioning the Jewish role in Pharma profiteering, writing:
On a broader level though, it seems clear that whatever drug we’re talking about, white people are generally the ones making profit and accessing it freely, while black people of color are being perpetually kept at the bottom of the ladder, experiencing trauma from the war on drugs which continues to affect them, and unable even to legally seek out medications for mental or physical pain that white people have readily available to them.
The NLG cites a study as that found that compared to Blacks, Whites are 75% more likely to be prescribed opioids for abdominal pain and 49% more likely to be prescribed opioids for back pain (but without a statistically significant difference in prescriptions for toothaches, large bone fractures, or kidney stones).
Even though the FDA long approved and facilitated the flow of opioids into poor White communities, the NLG compares the treatment of White drug addicts to the coddling of a child. While discussing a widely-covered study that was the subject of articles in the New York Times, the Guardian, the Atlantic, and the Huffington Post the NLG has the chutzpah to write:
Now with the opioid crisis affecting mainly white communities, its victims are being treated more similarly to children who deserve the utmost compassion for a disease they can’t control. Less discussed are the many studies that reflect how racial bias in the medical community affects the overall amount in which opioids are actually prescribed to black people and why it is seen as an issue affecting mainly whites.
The NLG blames this prescription gap on “conscious and unconscious bias” against Blacks in the medical field. It prescribes even more affirmative action to increase the number of Black physicians. The article further links to the #WhitecoatsforBlacklives student group which keeps “a racial justice scorecard that evaluates an academic center’s curriculum and climate, student and faculty diversity, policing, racial integration of clinical care sites, treatment of workers, and research protocols” a.k.a. works to push Whites out of the medical field and inculcate medical students with anti-White propaganda.
Let’s call the NLG/NPR/Teen Vogue hypothesis for the disproportionate number of White deaths from opioids, the White Privilege Hypothesis and explore the alternate explanations for disparate rates in opioid prescription, use, and overdoses among Whites.
To counter this narrative, I aim to demonstrate that:
1. There is little discrimination against Blacks in pain prescriptions
2. Disparities in back and abdominal pain prescriptions are not driving the opioid crisis
Therefore, the White Privilege Hypothesis cannot explain the disparate impact of opioids on Whites.
Instead the cause is a combination of:
1. Opioid marketing that targeted majority White counties
2. The economically-depressed regions hit hardest by the epidemic are largely White
3. The spiritual death of Whites analogous to that of the Indians
4. Purdue’s targeting of the elderly
5. Purdue’s targeting of Veterans
Right off the bat, the study cited by the NLG, Guardian, New York Times, Atlantic, and Huffington Post of racial disparities in Emergency Department prescriptions and administrations of opioids had two self-admitted major limitations:
First: it could not account for patient-initiated demand, which can increase prescriptions to Whites if Whites are more likely to request or know about their opioid options.
Second: it could not account for regional disparities in opioid treatments when the opioid epidemic tends to hit particular economically-depressed regions where Whites disproportionately live.
I would add a third:
The study adjusted its results for self-reported pain severity, categorized into none (pain score = 0), mild/moderate (pain score = 1–6), severe (pain score = 7–10) and unknown (pain score = 99 or missing).
The study notably does not examine whether Blacks were more likely to report severe pain than Whites. The study takes it as a given that a self-reported 7 by a White and a self-reported 7 by a Black mean the same thing. If pain severity did not affect the relative racial rate of prescriptions, why did the study authors feel the need to “correct” for it?
If Blacks are empirically more likely than Whites to claim higher pain levels, then physicians could be compensating by turning down their requests more frequently. Indeed, Adam T. Hirsh of the School of Science at Indiana University-Purdue conducted an evidence-based review and analysis of clinical and experimental studies that included a total of 2,719 black and 3,770 White adults. The metanalysis found that Blacks report higher levels of pain than Whites for a number of conditions including AIDS, glaucoma, arthritis, post-operative pain and lower-back pain (one of the two injuries where the NLG-cited study found disparate prescriptions). Blacks were more likely than Whites to think about their pain in a catastrophic manner. Furthermore, stoically ignoring pain rather than allowing it to interfere with the task at hand, known as task persistence, was the only coping strategy employed by Whites more than Blacks.
Physicians’ scrutiny of Black medical complaints is also not unfounded. Blacks make up approximately 13% of the American population, but 17% of Social Security Disability beneficiaries. The NLG also complained that Blacks were twice as likely to be monitored for illicit drug use when prescribed opioids, but given that Blacks are about 2.2 times more likely to be arrested for drug offenses proportional to their population, the precaution seems warranted.
I will note in passing that the study that began this controversy was published on the “open source” journal PLOS-ONE, which has drawn criticism for its model of having its authors pay for the publishing of their articles and for the sheer number of papers they pump out (22,054 in 2015). The journal leadership, like all of academia, is hostile to normal people. When Brown University School of Public Health Assistant Professor Lisa Littman published her findings on rapid onset gender dysphoria clustering among young people, the Editor-in-chief rushed to condemn her faster than an Ethiopian sprinter competing for a sandwich.
Tearing Down the Jews’ White Privilege Narrative on Opioids
Even if we accept the very questionable assumption that Blacks are discriminated against for pain prescriptions, and only for abdominal and back pain at that, there is still no governing connection between opioid prescription rates and racial overdose death rates. Indeed, since Whites die of opioid overdoses at 150% the rate of Blacks and 285% the rate of Hispanics, if the White Privilege Hypothesis were true the one would expect that Hispanics would be prescribed opioids at an even lower rate than Blacks. In fact, Hispanics were prescribed opioids for abdominal and back pain at a rate between Whites and Blacks, which was not statistically different from the White prescription rate.
Many of the overdoses may be suicides or at the very least actions by individuals indifferent to whether they live or die. Whites commit suicide at nearly three times the rate of Blacks and Hispanics. In 2017, the age-adjusted rate of suicide among non-Hispanic Whites was 17.83 per 100,000 and among. In contrast, the rate for Blacks was 6.85, and the rate among Hispanics was 6.89. The White-Black-Hispanic overdose disparities correlate far better with suicide rates than the NLG-cited study which only found significant racial disparities in prescriptions among two out of five conditions surveyed and then only between Whites and Blacks.
Marketing as the Driver
Another alternative to the White Privilege Hypothesis, focuses on the targeting of majority-White counties by opioid companies. In his original article Eric Striker described how, Mad Mensch, Arthur Sackler got his start at a Manhattan ad agency, eventually buying it outright. The Sacklers then proceeded to push their medicine through the world’s first informercials and the medical journals they owned. Purdue’s dry-run for the opioid crisis was the Valium bonanza they kicked off with a marketing campaign that made “mommy’s little helper” (invented by the Jew Leo Sternbach) the best-selling American medication between 1968 and 1982.
The Sackler Jews continued their unethical pioneering in medical innovation, this time using the internet. The Massachusetts AG’s lawsuit alleges that Purdue purchased online advertising seen nearly 4 million times for OxyContin and more than 5 million times for Butrans (another opioid). The Burtrans opioid was further pushed with a marketing campaign that sent 880,000 emails to medical professionals. In addition to online ads and emails, the Sacklers stuck to their typical tricks of paying for free vacations for doctors under the guise of medical conferences and buying supplements in medical journals.
By cross referencing CDC county level data on opioid overdoses with the total of all compensation and gifts to a physician designated as marketing an opioid (as required by Obamacare), researchers found:
The 1983 White majority counties in America that were targeted by opioid marketing received an average of $1.88 in marketing for every 1,000 population.
The 67 Black majority counties were targeted with $1.11 in marketing per 1,000.
The 44 Hispanic majority counties were targeted with $1.36 in marketing per 1,000.
The 11 counties with a racial majority of a race that is not White, Hispanic, or Black which are probably American Indian-majority counties, were targeted with $2.54 in opioid marketing per 1,000.
The average of all counties that received opioid marketing, including those with no majority of any race, was $1.57 in funding per 1,000 population.
The result is that among counties that received opioid marketing, majority White counties received 20% more than average in opioid marketing, 69% more than Black majority counties, and 38% more than Hispanic majority counties.
The racial disparities in marketing are important because in the same county-by-county analysis, the researchers found that when drug companies increased their opioid marketing budgets by just $5.29 per 1,000 population, the number of opioid prescriptions written by doctors went up by 82 percent and the opioid death rate was 9 percent higher a year later.
The marketing efforts also concern a self-admitted flaw to the racial opioid prescription data. The study did not account for racial differences in patient requests for opioids. In a study where doctors were shown a video scenario of a patient request for pain medication, about 20 percent of patients requesting oxycodone would receive it, compared to one percent of those making no specific request. This, in spite of the fact that strong narcotic pain relievers such as oxycodone were generally not recommended for the malady depicted. If marketing moved Whites to request oxycodone specifically, it may help account for the disproportionate racial impact.
Whites lie at the center of the Geographic Hotspots of overdoses
Syracuse University Professor Shannon Monnat’s May 2019 paper in the Journal of Rural Studies identified factors that correlate to White drug deaths at the county level:
greater economic and family distress,
dependence on mining or service employment,
persistent population loss,
higher rates of prescribing, proximity to high-prescribing counties,
counties located in states with high fentanyl exposure (mostly the Northeast)
One study further demonstrated that as the county unemployment rate increases by one percentage point, the opioid mortality rate increases by 3.6 percent. Longstanding economic distress, dependence on often painful mining and service industry work, and the breakdown of family networks combined into a potent cocktail of death in several opioid super regions.
The New York Times’s mapping of the opioid crisis demonstrates the geographic element of the contagion. One region would become hooked to pain pills and over time the addiction would both worsen and spread out. Opioid hot spots, like malignant tumors, can be tracked and identified in Appalachia, New England, New Mexico, Oklahoma, and Florida.
Whites, of course, were generally at the center of these regions. The second flaw in the NLG-cited study was that there was no control for proximity to other opioid-inundated counties. As opioid use becomes normalized and prescriptions increase, illicit access to opioids and demand in neighboring counties may also increase.
Drug companies directed ungodly quantities of drugs to rural towns and pharmacies. According to an investigation by the House Committee on Energy and Commerce drug wholesalers sent 20.8 million prescription painkillers to two pharmacies in a West Virginia town of 3,000 from 2008 to 2015. Perhaps they bet that no one would care if a few thousand White ruralites died off.
The Sacklers Deliberately Targeted the Elderly
Non-Hispanic Whites make up 78.3% of the over-65 population, compared to 57.4% of the under-65 population. Under Purdue’s “geriatric strategy,” the dying Greatest Generation was easy prey for the same Jews they supposedly fought to save from National Socialism. Purdue produced numerous marketing materials intended to sell doctors on the pressing need to prescribe opioids to the elderly.
Purdue knew their drugs had a higher rate of adverse reactions in the elderly. Their drugs would also accentuate the risk of respiratory depression whereby our grandfathers’ and grandmothers’ lungs become unable to pump out enough carbon dioxide. How many thousands of our elders slowly choked to death, lonely and unknow, in the nursing homes where we abandoned them?
The Sacklers Deliberately Targeted Veterans
According to the VA, in 2017, 78.0% of Veterans were White-non-Hispanic compared to the 60.6% Non-Hispanic general population. Jews like the Sacklers are almost certainly underrepresented in this number given that they make up 0.3% of our armed forces, despite being 2.1% of the population. Perhaps even more despicably, there were 500 instances of Purdue sales reps emphasizing the targeting of TriCare insured-patients at sales meetings. In other words, Purdue targeted veterans and their families.
As described in the state’s lawsuit, Massachusetts Veterans were 3 times more likely to die of opioid overdoses than the general population. Purdue funded and distributed a book to Veterans that contained the false claim that opioids were not addictive and that Oxy was a good choice for post deployment pain. The title: Exit Wounds: A Survival Guide to Pain Management for Returning Veterans and Their Families. While Pro-White Books are pulled from Amazon, Purdue’s fake book to get American heroes hooked on Oxy is still available.
De-Racination Drives Addiction
Drug overdose rates among American Indians track almost identically to White Americans. The Indians are important in demonstrating our counter to the White Privilege Hypothesis because they are affected by five of the factors affecting Whites, but not Blacks or Hispanics:
First, and perhaps most importantly, the Indians have experienced the spiritual death that Whites are going through right now. The preferred term is “historical trauma” which certainly appeals to the liberals who presently hold the purse strings of government. Whatever it is called, the dispossession of a people of the lands of their ancestors will have profound physiological consequences for White or Indian.
Second, Indians are near the center of several of the “opioid hot spots,” most notably Oklahoma and New Mexico.
Third, majority-Indian, like majority White counties were targeted for opioid marketing at a higher-than-average rate ($2.54 per 1,000 population vs. an average $1.57).
Fourth, like Whites, Indians also disproportionately live in the economically-depressed counties dependent on the mining and service industries that have the highest drug death rates.
Fifth, like Whites, Indians also have a suicide rate roughly 3 times higher than Blacks and Hispanics. This supports the “Deaths of Despair” explanation whereby racial suicide rates correlate better with drug overdoses than opioid prescription rates.
Though Black overdose rates have climbed in recent years, this trend is driven by the introduction of cheap and deadly fentanyl, not the original prescriptions backed by multi-million ad campaigns from pharma Jews. Meanwhile the Hispanic and Asian overdoes rates have remained relatively low. The explanation: unlike Whites and Indians who face outright dispossession, Asians and Hispanics are ascendant in America.
The Sackler “Philanthropy” Unmasked
Can the Sacklers be demonstrated to have not only a motive of greed, but a driving hatred of the White Folk? All that is required is to contrast the Sackler philanthropists’ generosity with their ‘medicine’ with the way they spread they monetary donations.
The Sacklers were more than happy to spend a portion of their wealth funding degenerate modern art in New York, London, and DC. The Sacklers also donated heavily to the architectural monstrosity that is the Jewish Museum in Berlin. Their philanthropy differed slightly in Israel where they sponsored a medical school. The Sackler School of Medicine: healing Jews with money drenched with the blood of the Goyim.
Why didn’t these magnanimous individuals send their pills to their beloved Israel? Why was the Jewish State spared from this magical cure for pain? Why were American, not IDF, veterans targeted for opioid sales? Part of the answer, of course, is that Israel has a socialist medical system whereby their people are not seen as mere packages of stock shares for medical corporations to plunder. But foremost I hold the opioid crisis is the inevitable result of the application of Jewish organized criminality to modern medicine.
While the Sacklers funded London’s Tate Modern, the Guggenheim, and the Center for Feminist Art at the Brooklyn Museum, the pills went to West Virginia. While they built libraries at Oxford and sponsored the Columbia Sackler Institute for Developmental Psychobiology in New York City, untold thousands of White babies from Maine to Washington were born addicted to opioids.
The opioid crisis was a deliberate attempt by Jewish drug dealers to kill off or pacify our people, and the White Privilege Hypothesis of opioid addiction is just another example of Jewish blame-shifting.
The National Lawyers Guild, NPR, and the New York Times want you to believe that the fault lies not with the Sackler family who spent some 70 years cooking up marketing schemes to get the Goyim hooked on their patent medicine—but rather working-class Whites. Those Whites who had the audacity to trust their doctors after years of sacrificing their bodies on the altar of our industrial economy.
Our dead will not be forgotten, and perhaps someday—after years of political soldiering, of jailing, of violence directed at us, on a day most of us will not live to see—our children will stand in control of this nation’s courts. Perhaps they can administer the Old Testament justice these international pharmaceutical parasites have earned. The 400,000 dead deserve no less.
 FB Ahmad, LA Escobedo, LM Rossen, MR Spencer, M Warner & P Sutton, Provisional drug overdose death counts, National Center for Health Statistics (May 15, 2019), https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
 CDC, Div. of Unintentional Injury Prevention, Opioid Overdose: Understanding the Epidemic, CDC (December 19, 2018), https://www.cdc.gov/drugoverdose/epidemic/index.html.
 Kaiser Family Foundation, Opioid Overdose Deaths by Race/Ethnicity, KFF, https://www.kff.org/other/state-indicator/opioid-overdose-deaths-by-raceethnicity/?currentTimeframe=0&selectedRows=%7B%22wrapups%22:%7B%22united-states%22:%7B%7D%7D%7D&sortModel=%7B%22colId%22:%22White,%20Non-Hispanic%22,%22sort%22:%22desc%22%7D (last visited May 19, 2019).
 Brian Broome, Amid the opioid epidemic, white means victim, black means addict, The Guardian, (Apr. 28, 2018) https://www.theguardian.com/us-news/2018/apr/28/opioid-epidemic-selects-white-victim-black-addict.
 Melissa Healy, Why opioids hit white areas harder: Doctors there prescribe more readily, study finds, LA Times, (Feb. 11, 2019) https://www.latimes.com/science/sciencenow/la-sci-sn-opioids-whites-doctors-20190211-story.html.
 All Things Considered, Why Is The Opioid Epidemic Overwhelmingly White?, NPR (Nov. 4, 2017), https://www.npr.org/2017/11/04/562137082/why-is-the-opioid-epidemic-overwhelmingly-white.
 NIDA, Prescription opioid use is a risk factor for heroin use, National Institute on Drug Abuse, https://www.drugabuse.gov/node/pdf/19774/prescription-opioids-and-heroin (last updated Jan. 2018).
 HHS Press Office, HHS Awards Over $1 Billion to Combat the Opioid Crisis, HHS, (Sep. 19, 2018) https://www.hhs.gov/about/news/2018/09/19/hhs-awards-over-1-billion-combat-opioid-crisis.html.
 Jan Hoffman, Can This Judge Solve the Opioid Crisis?, NYTimes, (Mar. 5, 2018). https://www.nytimes.com/2018/03/05/health/opioid-crisis-judge-lawsuits.html
 Jeff Overly, Media Can’t Access Drug Co. Data In Opioid MDL, LAW360, (Jul. 26, 2018) https://www.law360.com/articles/1067569/media-can-t-access-drug-co-data-in-opioid-mdl.
 Amanda Koehn, Judge: Government Officials Questioning Federal Judges Undermines Legitimacy, Cleveland Jewish News, (Feb. 10, 2017) https://www.clevelandjewishnews.com/news/local_news/judge-government-officials-questioning-federal-judges-undermines-legitimacy/article_f4abf3cc-eeef-11e6-8a44-9781e7a0bc50.html.
 NASDAQ, Endo International plc Institutional Ownership, NASDAQ (Apr. 10, 2019) https://web.archive.org/web/20190410205329/https://www.nasdaq.com/symbol/endp/institutional-holdings.
 Lenny Bernstein & Scott Higham, Former Top Justice Official Went to Bat for Drug Giant Cardinal Health, Washington Post, (Nov. 17, 2017) https://www.washingtonpost.com/national/health-science/former-top-justice-official-went-to-bat-for-drug-giant-cardinal-health/2017/11/17/3ca82188-c400-11e7-afe9-4f60b5a6c4a0_story.html?noredirect=on&utm_term=.50b1e81bfb7c.
 Astha Singhal, Yu-Yu Tien & Renee Y. Hsia, Racial-Ethnic Disparities in Opioid Prescriptions at Emergency Department Visits for Conditions Commonly Associated with Prescription Drug Abuse. PLoS ONE 11(8): e0159224. (2016). https://doi.org/10.1371/journal.pone.0159224.
 Samantha M. Meints, Megan M. Miller, Adam T. Hirsh. Differences in pain coping between Black and White Americans: A meta-analysis. The Journal of Pain, 2016; DOI: 10.1016/j.jpain.2015.12.017.
 QuickStats: Age-Adjusted Suicide Rates,by Race/Ethnicity — National Vital Statistics System, United States, 2015–2016. MMWR Morb Mortal Wkly Rep 2018;67:433. DOI: http://dx.doi.org/10.15585/mmwr.mm6714a6external icon.
 Criminal Justice Fact Sheet, NAACP, https://www.naacp.org/criminal-justice-fact-sheet/ (last visited May 21, 2019).
 Joerg Heber, Correcting the scientific record on gender incongruence – and an apology, PLOS ONE, (Mar. 19, 2019) https://blogs.plos.org/everyone/2019/03/19/correcting-the-scientific-record-and-an-apology/.
 Racial and Ethnic Disparities, Suicide Prevention Resource Center, https://www.sprc.org/racial-ethnic-disparities (last visited May 21, 2019) (CDC 2017 data).
 Ian Sample, Leo Sternbach, The Guardian, (Oct. 2, 2005) https://www.theguardian.com/society/2005/oct/03/health.guardianobituaries.
 First Amended Complaint and Jury Demand at 143, Commonwealth v. Purdue Pharma, No. 1884-cv-01808 (Mass. Sup. Ct. Jan. 31, 2019) (https://www.documentcloud.org/documents/5715954-Massachusetts-AGO-Amended-Complaint-2019-01-31.html).
 Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses. JAMA Netw Open. 2019;2(1):e186007. DOI:10.1001/jamanetworkopen.2018.6007.
 John B. McKinlay, Felicia Trachtenberg, Lisa D. Marceau, Jeffrey N. Katz, Michael A. Fischer. Effects of Patient Medication Requests on Physician Prescribing Behavior. Medical Care, 2014; 52 (4): 294 DOI: 10.1097/MLR.0000000000000096.
 Shannon M. Monnat, The contributions of socioeconomic and opioid supply factors to U.S. drug mortality rates: Urban-rural and within-rural differences, 68 Journal of Rural Studies, 319-335 (2019).
 Hollingsworth, A., Ruhm C.J., and Simon, K., Macroeconomic Conditions and Opioid
Abuse. (NBER Working Paper No. 23192, 2017).
 Laurel Wamsley, Drug Distributors Shipped 20.8 Million Painkillers To West Virginia Town Of 3,000, NPR (Jan. 30, 2018) https://www.npr.org/sections/thetwo-way/2018/01/30/581930051/drug-distributors-shipped-20-8-million-painkillers-to-west-virginia-town-of-3-00.
 Mark Mather, Fact Sheet: Aging in the United States, Population Research Bureau, (Jan 13, 2016) https://www.prb.org/aging-unitedstates-fact-sheet/.
 QuickFacts, U.S. Census, https://www.census.gov/quickfacts/fact/table/US/RHI825217 (accessed Apr. 10, 2019).
 First Amended Complaint and Jury Demand, supra note 19, at 50-53.
 Nat’l Ctr. for Veterans Analysis and Statistics, Profile of Veterans: 2017, U.S. Dep. of Veterans Affairs (Mar. 2019) https://www.va.gov/vetdata/docs/SpecialReports/Profile_of_Veterans_2017.pdf
 Raw Data: Religious preference in the military, CNN, (Nov. 12, 2009) http://ac360.blogs.cnn.com/2009/11/12/raw-data-religious-preference-in-the-military/
 Ira M. Sheskin & Arnold Dashefsky. “United States Jewish Population, 2017,” in Arnold Dashefsky and Ira M. Sheskin. (Editors) The American Jewish Year Book, 2017, Volume 117 (2017) (Dordrecht: Springer) pp. 179-284 https://www.jewishdatabank.org/content/upload/bjdb/US_Jewish_Population_2017_AJYB_DataBank_Final.pdf.
 First Amended Complaint and Jury Demand, supra note 19, at 54
 Id., at 54-57
 Josh Katz & Abby Goodnough, The Opioid Crisis Is Getting Worse, Particularly for Black Americans, NY Times, (Dec. 22, 2017) https://www.nytimes.com/interactive/2017/12/22/upshot/opioid-deaths-are-spreading-rapidly-into-black-america.html.
 Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses, JAMA Netw Open, 2019;2(1):e186007. DOI:10.1001/jamanetworkopen.2018.6007.